Results 141 to 150 of about 4,425,847 (185)

Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression. [PDF]

Mol Ther Oncolytics, 2018
Wang M, Hong Y, Feng Q, Pan X, Song S, Cui J, Lei J, Fang H, Yang J.   +8 more
europepmc   +1 more source

Safety and efficacy of cytokine-induced killer cells for gastric cancer: a systematic review and meta-analysis. [PDF]

Front Oncol
Zhu M, Yang C, Liang B, Liu Q.
europepmc   +1 more source

Harnessing immunity against breast cancer: from checkpoints to cell therapies. [PDF]

J Transl Med
Mussa A, Hamid M, Talib M, Ismail NH, Lambuk F, Bishir AD, Memon MA, Lukman Y, Suliman R, Yagoub A, Hajisa K, Mokhtar NF, Marincola FM, Mohamud R, Hassan R, Al-Hatamleh MAI.   +15 more
europepmc   +1 more source

Advances in improving cancer immunotherapy with nanotechnology: from smart nanoparticles to synergistic combination strategies. [PDF]

Mol Cancer
Cho U, Pu J, Sharma A, Song J, You JH, Kim Y, Im PW, Park HW, Moon HE, Myeong HS, Park HR, Hou J, Schmidt-Wolf IGH, Paek SH.   +13 more
europepmc   +1 more source

Grass carp reovirus activates fish Ppp1r3g to suppress innate immunity and exacerbate hemorrhage via the 14-3-3ζ/Itgb3 signaling axis. [PDF]

PLoS Pathog
Wang R, Zhou M, Wang Y, Hu X, Zhang H, Cao H.   +5 more
europepmc   +1 more source

Therapeutic potential of cytokine-induced killer cell therapy for renal cell carcinoma and prostate cancer. [PDF]

Cell Commun Signal
Lee IT, Wang YL, Hong JH, Huang CY, Vo TTT, Lee WJ, Chiang CH.   +6 more
europepmc   +1 more source

First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia. [PDF]

J Clin Oncol
Rettinger E, Heckl D, Hutter M, Salzmann-Manrique E, Luedtke M, Huenecke S, Bremm M, Cappel C, Bug G, Greil J, Meisel R, Wagner-Drouet EM, Serve H, Güngör T, Klusmann JH, Klingebiel T, Bader P, Bonig H.   +17 more
europepmc   +1 more source

Efficacy of modified dendritic cell-cytokine-induced killer cells loaded with tumour stem cell membrane microparticle therapy in the treatment of relapsed or refractory T- and NK-cell lymphoid proliferations and lymphomas: a report of three cases. [PDF]

Ann Hematol
Wang A, Fan T, Zhang J, Ye M, Huang H, Gao ZL.   +5 more
europepmc   +1 more source

Non-Genetically Modified Adoptive Cell Therapies for Solid Tumors: Current Landscape and Future Challenges. [PDF]

Cancer Immunol Immunother
Luo Q, Jiang W, Xie Y, Dai Z, Zhu J, Du Y, Tao X, Lei Z, Chu X, Wang B, Fu G.   +10 more
europepmc   +1 more source